Valeria Baldivieso Hurtado, MD
Geriatric Medicine · Winter Park, FLNPI 1225422074
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $21,084 of the $27,597 with a category attached, or 76.4%. 10 manufacturers reported payments, led by Novo Nordisk at 59.8% of the total. Reporting peaked in 2024 at $18,598 and has fallen 53.5% since, to $8,649 in 2025. Among geriatric medicine clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 61 payments — averaging $452.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$16K
- Lilly USA, LLC$9K
- Eisai Inc.$2K
- Astellas Pharma US Inc$44
- Microtransponder, Inc.$36
- Johnson & Johnson$34
- plus $80 from 4 others
Across 23 payments — averaging $5356.35 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Genentech, Inc.$61K
- GSK$35K
- Insightec,ltd$28K
What the payments were for
- Consulting fees$21,08476%
- Travel & lodging$4,48816%
- Food & beverage$2,0267%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 16 | $16,498 |
| Lilly USA, LLC | 33 | $8,913 |
| Eisai Inc. | 2 | $1,992 |
| Astellas Pharma US Inc | 2 | $44 |
| Microtransponder, Inc. | 1 | $36 |
| Johnson & Johnson | 2 | $34 |
| GSK | 2 | $30 |
| Abbott | 1 | $22 |
| Dexcom, Inc. | 1 | $14 |
| Merck | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$27,597 in reported general payments places this provider in the 95th percentile of 305 geriatric medicine providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Memantine Hcl | 259 | $9,581 |
| Rivastigmine | 33 | $9,551 |
| Memantine Hcl ErMemantine Hcl | 27 | $3,653 |
| Donepezil Hcl | 263 | $3,004 |
| RivastigmineRivastigmine Tartrate | 35 | $2,319 |
| Quetiapine Fumarate | 56 | $1,354 |
| Sertraline Hcl | 94 | $605 |
| Mirtazapine | 28 | $516 |
| Fluoxetine Hcl | 24 | $509 |
| Risperidone | 20 | $508 |
| Buspirone Hcl | 27 | $469 |
| Escitalopram Oxalate | 32 | $427 |
| Duloxetine Hcl | 14 | $335 |
| Trazodone Hcl | 53 | $289 |
| Citalopram HbrCitalopram Hydrobromide | 11 | $83 |
Paid to pharmacies, not to this prescriber.
Other geriatric medicine in Winter Park
- Malcolm FraserBrooksville$359K
- Andrew ScanameoTallahassee$172K
- Naushira PandyaDavie$145K
- Rosemary LairdViera$64K
- Jonathan AppelbaumMonticello$59K
- John PotomskiMelbourne$31K
- Kae FerberNaples$18K
- Stuti DangMiami$17K
- Angel HerreraNaples$12K
- Jason StibichBrandon$11K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.